Cramer: Apple Is Th...
Health Care: Health Services
Covidien PLC (COV: NYSE)
$50.67 -1.11 | -2.14%
06/01/12 - 04:01 PM ET
Company Income Statement
| Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | |
| Sales | 11.57B | 10.43B | 10.68B | 9.91B |
| Cost of Sales | 4.40B | 4.14B | 4.50B | 4.20B |
| Gross Operating Profit | 7.18B | 6.29B | 6.18B | 5.71B |
| Selling, General, and Administrative Expenses | 3.54B | 3.22B | 3.09B | 2.88B |
| Research & Development | 554.00M | 447.00M | 438.00M | 341.00M |
| Operating Income before D & A (EBITDA) | 3.08B | 2.63B | 2.66B | 2.48B |
| Depreciation & Amortization | 599.00M | 489.00M | 440.00M | 398.00M |
| Interest Income | 22.00M | 22.00M | 25.00M | 43.00M |
| Other Income - Net | 33.00M | 40.00M | -38.00M | 199.00M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | -42.00M |
| Total Income Before Interest Expenses (EBIT) | 2.42B | 2.12B | 2.03B | 2.19B |
| Interest Expense | 203.00M | 199.00M | 175.00M | 209.00M |
| Pre-Tax Income | 2.22B | 1.93B | 1.85B | 1.98B |
| Income Taxes | 333.00M | 363.00M | 949.00M | 536.00M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 1.88B | 1.56B | 902.00M | 1.44B |
| Net Income From Discontinued Operations | -15.00M | 69.00M | 5.00M | -82.00M |
| Net Income From Total Operations | 1.87B | 1.63B | 907.00M | 1.36B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 1.87B | 1.63B | 907.00M | 1.36B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.00B | 1.64B | 1.08B | 1.58B |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 1.88B | 1.56B | 902.00M | 1.44B |
| Basic EPS from Continuing Ops. | 3.82 | 3.13 | 1.79 | 2.89 |
| Basic EPS from Discontinued Ops. | -0.03 | 0.14 | 0.01 | -0.16 |
| Basic EPS from Total Operations | 3.79 | 3.27 | 1.80 | 2.73 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | -0.01 | 0.00 | 0.00 |
| Basic EPS, Total | 3.79 | 3.26 | 1.80 | 2.73 |
| Basic Normalized Net Income/Share | 4.07 | 3.28 | 2.14 | 3.17 |
| EPS fr Continuing Ops. | 3.79 | 3.10 | 1.78 | 2.86 |
| EPS fr Discontinued Ops | -0.03 | 0.14 | 0.01 | -0.16 |
| EPS fr Total Ops. | 3.76 | 3.24 | 1.79 | 2.70 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 3.76 | 3.24 | 1.79 | 2.70 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
4.04 | 3.25 | 2.13 | 3.14 |
| Dividends Paid per Share | 0.60 | 0.92 | 0.64 | 0.64 |
Portfolios with COV
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- ProJohn Paulson
- ContributorTop-Yielding Health Service...
- UserGFNN Stockdiagnostics 4
- ProKaren Finerman - Metropolit...
- ProPrivate Capital Management
- ContributorHealth Care Stocks Bought a...
- ContributorJohn Paulson's 10 Best New ...
- Contributor8 Health Care Stocks to Buy
- ProTPG-Axon Capital
Latest COV Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.24.12 | 05:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.08.12 | 04:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.01.12 | 05:05 pm
- Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript 04.27.12 | 01:04 pm
- Covidien Stock To Go Ex-dividend Monday (COV) 03.30.12 | 09:03 am
- 8 Ex-Dividend Stocks With Buy Ratings 03.30.12 | 05:03 am
- Tyco Investors Not Free From Kozlowski 03.29.12 | 09:03 am
- Pfizer Needs to Think About Splitting: Goldman 03.27.12 | 03:03 pm
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
Press Releases for COV
- Endo GIA(TM) Radial Reload With Tri-Staple(TM) Technology (Photo: Business Wire) - Business Wire 05.31.12 | 06:05 pm
- Covidien To Present At Goldman Sachs Conference - Business Wire 05.31.12 | 07:05 am
- Covalon Provides Corporate Update And Second Quarter Fiscal 2012 Financial Results - PR Newswire 05.28.12 | 08:05 am
- Covidien Announces Pricing Of $1.250 Billion Senior Notes Offering - Business Wire 05.22.12 | 04:05 pm
- Covidien Announces Senior Notes Offering And Redemption Of 5.450% Senior Notes Due October 2012 - Business Wire 05.22.12 | 09:05 am
- Covidien Appoints Gregory S. Andrulonis Vice President And Treasurer - Business Wire 05.21.12 | 04:05 pm
- Covalon To Unveil Its SilverCoat⢠Antimicrobial Silicone Foley Catheter At The 2012 American Urological Association Annual Meeting In Atlanta - PR Newswire 05.18.12 | 01:05 pm
- Covidien Completes Acquisition Of SuperDimension, Ltd. - Business Wire 05.15.12 | 04:05 pm
- Covalon Announces Major Milestone: Achieves FDA Approval For IV Clear⢠- A Breakthrough Antimicrobial Silicone Adhesive Film Dressing For Securing Vascular Access Medical Devices - PR Newswire 05.15.12 | 08:05 am
- Covidien, A Leading Global Provider Of Healthcare Products, Will Unveil Its New OneShot™ Renal Denervation System At The EuroPCR Congress In Paris, France, On May 16, 2012. (Photo: Business Wire) - Business Wire 05.08.12 | 07:05 am
Partner Headlines for COV
- COV Launches Endo GIA Radial Reload - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Covidien Prices Senior Notes - Analyst Blog - Zacks 05.25.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom and NOV, COV, ABVT, TNB - GuruFocus 05.17.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom - GuruFocus 05.17.12 | 04:05 pm
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- UPDATE: Deutsche Bank Raises PT to $62 on Covidien; FQ2 Beats Expectations - Benzinga 05.01.12 | 09:05 am
- Covidien to Acquire Oridion Systems - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- Covidien Takes Over superDimension - Analyst Blog - Zacks 04.03.12 | 09:04 am
- Covidien Announces Study Results Demonstrating Benefits of Minimally Invasive Surgery over Traditional Open Procedures - Benzinga 03.12.12 | 04:03 pm
- The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases - Zacks 03.08.12 | 09:03 am
